Paradigm Biocapital Advisors LP

Insider Reports History

Entity: Company
Location: 767 Third Avenue, 17 Th Floor, New York, NY
Signature: /s/ David Kim, as an authorized signatory of the Fund and the Adviser GP (for itself and on behalf of the Adviser)
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Paradigm Biocapital Advisors LP:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Olema Pharmaceuticals, Inc.	10%+ Owner	Common Stock, par value $0.0001 per share	6.59M	$76.5M	$11.60	Dec 6, 2023	By: Paradigm BioCapital International Fund Ltd.
Olema Pharmaceuticals, Inc.	10%+ Owner	Common Stock, par value $0.0001 per share	4.72M	$70.4M	$14.92	Aug 1, 2024	By: Paradigm BioCapital International Fund Ltd.
Olema Pharmaceuticals, Inc.	10%+ Owner	Common Stock, par value $0.0001 per share	1.31M	$15.2M	$11.60	Dec 6, 2023	By: One or more separately managed accounts
Olema Pharmaceuticals, Inc.	10%+ Owner	Common Stock, par value $0.0001 per share	783K	$11.7M	$14.92	Aug 1, 2024	By: One or more separately managed accounts

Showing 1 to 4 of 4 entries

Insider Reports Filed by Paradigm Biocapital Advisors LP

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
OLMA	Olema Pharmaceuticals, Inc.	Aug 1, 2024	2	-$35.8M	4	Aug 5, 2024	10%+ Owner
OLMA	Olema Pharmaceuticals, Inc.	Dec 6, 2023	1	$1.16M	4	Dec 8, 2023	10%+ Owner
OLMA	Olema Pharmaceuticals, Inc.	Sep 12, 2023	0	$0	3	Sep 21, 2023	10%+ Owner